Prerequisites to implementing a pharmacogenomics program in a large health-care system

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

Pharmacogenomics (PGx) technology is advancing rapidly; however, clinical adoption is lagging. The Indiana Institute of Personalized Medicine (IIPM) places a strong focus on translating PGx research into clinical practice. We describe what have been found to be the key requirements that must be delivered in order to ensure a successful and enduring PGx implementation within a large health-care system.

Original languageEnglish (US)
Pages (from-to)307-309
Number of pages3
JournalClinical Pharmacology and Therapeutics
Volume96
Issue number3
DOIs
StatePublished - 2014

Fingerprint

Precision Medicine
Pharmacogenetics
Technology
Delivery of Health Care
Research

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

@article{425a9f77112d45ae83aefe63227cae8f,
title = "Prerequisites to implementing a pharmacogenomics program in a large health-care system",
abstract = "Pharmacogenomics (PGx) technology is advancing rapidly; however, clinical adoption is lagging. The Indiana Institute of Personalized Medicine (IIPM) places a strong focus on translating PGx research into clinical practice. We describe what have been found to be the key requirements that must be delivered in order to ensure a successful and enduring PGx implementation within a large health-care system.",
author = "Kenneth Levy and Brian Decker and Janet Carpenter and Flockhart, {D. A.} and Paul Dexter and Zeruesenay Desta and Todd Skaar",
year = "2014",
doi = "10.1038/clpt.2014.101",
language = "English (US)",
volume = "96",
pages = "307--309",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "3",

}

TY - JOUR

T1 - Prerequisites to implementing a pharmacogenomics program in a large health-care system

AU - Levy, Kenneth

AU - Decker, Brian

AU - Carpenter, Janet

AU - Flockhart, D. A.

AU - Dexter, Paul

AU - Desta, Zeruesenay

AU - Skaar, Todd

PY - 2014

Y1 - 2014

N2 - Pharmacogenomics (PGx) technology is advancing rapidly; however, clinical adoption is lagging. The Indiana Institute of Personalized Medicine (IIPM) places a strong focus on translating PGx research into clinical practice. We describe what have been found to be the key requirements that must be delivered in order to ensure a successful and enduring PGx implementation within a large health-care system.

AB - Pharmacogenomics (PGx) technology is advancing rapidly; however, clinical adoption is lagging. The Indiana Institute of Personalized Medicine (IIPM) places a strong focus on translating PGx research into clinical practice. We describe what have been found to be the key requirements that must be delivered in order to ensure a successful and enduring PGx implementation within a large health-care system.

UR - http://www.scopus.com/inward/record.url?scp=84907874984&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907874984&partnerID=8YFLogxK

U2 - 10.1038/clpt.2014.101

DO - 10.1038/clpt.2014.101

M3 - Article

C2 - 24807457

AN - SCOPUS:84907874984

VL - 96

SP - 307

EP - 309

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 3

ER -